Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Distinctions between fraud, bias, errors, misunderstanding, and incompetence

D L DeMets1

  • 1Department of Biostatistics, University of Wisconsin-Madison Medical School 53792, USA.

Controlled Clinical Trials
|December 31, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistical issues in interpreting clinical trials.

Journal of internal medicine·2004
Same author

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.

Controlled clinical trials·2001
Same author

Statistical issues relating to international differences in clinical trials.

American heart journal·2001
Same author

Effect of carvedilol on survival in severe chronic heart failure.

The New England journal of medicine·2001
Same author

The Data and Safety Monitoring Committee: Some final thoughts.

American heart journal·2001
Same author

An overview of group sequential methods in longitudinal clinical trials.

Statistical methods in medical research·2001

Conducting randomized clinical trials presents challenges beyond design and analysis, including errors, bias, and fraud. Despite potential issues, these trials often remain robust enough for valid results, though some problems are intolerable.

Area of Science:

  • Clinical Research
  • Biostatistics
  • Medical Ethics

Background:

  • Randomized clinical trials (RCTs) are crucial for medical advancements but face significant challenges during their conduct.
  • Issues such as errors, misunderstandings, bias, incompetence, and fraud can compromise trial integrity.
  • Distinguishing between different types of problems and their implications is essential for scientific and public understanding.

Purpose of the Study:

  • To define common problems encountered in the conduct of randomized clinical trials.
  • To illustrate the impact of these issues on trial validity and interpretation.
  • To clarify the distinctions between various conduct-related challenges for scientists and the public.

Main Methods:

  • The study involves a conceptual analysis and discussion of potential problems in RCT conduct.

Related Experiment Videos

  • Examples will be used to illustrate the impact of identified issues.
  • Definitions of different problem categories will be provided.

    • Main Results:

    • RCTs often possess inherent robustness despite conduct challenges, yielding valid results.
    • Certain issues, such as significant bias or fraud, can render trial results unacceptable.
    • Clear definitions and understanding of conduct problems are necessary to maintain scientific rigor.

    Conclusions:

    • While RCTs can tolerate some level of error or misunderstanding, critical issues like bias and fraud undermine their validity.
    • Effective management and clear communication are vital to mitigate conduct problems in clinical trials.
    • Understanding the spectrum of conduct challenges ensures the reliability of evidence generated from randomized clinical trials.